Yayın:
A Dft Study of the Chemical Reactivity Properties of Alzheimer's Disease Medications

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKARABURUN, AHMET ÇAĞRI
dc.contributor.authorHalil Berber
dc.contributor.authorAhmet Çağrı Karaburun
dc.contributor.orcid0000-0002-7271-6791
dc.contributor.orcid0000-0003-3869-3861
dc.contributor.orcid0000-0002-2503-3824
dc.date.accessioned2025-11-13T19:37:23Z
dc.date.issued2022-01-01
dc.identifier.doi10.2139/ssrn.4113642
dc.identifier.issn1556-5068
dc.identifier.openalexW4285208349
dc.identifier.urihttps://hdl.handle.net/11421/11358
dc.identifier.urihttps://doi.org/10.2139/ssrn.4113642
dc.language.isoen
dc.relation.ispartofSSRN Electronic Journal
dc.rightsopenAccess
dc.subjectDisease
dc.subjectReactivity (psychology)
dc.subjectAlzheimer's disease
dc.subjectMedicine
dc.subjectPsychology
dc.subjectInternal medicine
dc.subjectAlternative medicine
dc.subjectPathology
dc.titleA Dft Study of the Chemical Reactivity Properties of Alzheimer's Disease Medications
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5062259142

Dosyalar

Koleksiyonlar

Publications